Identifying optimal candidates for liver resection or transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma

BACKGROUND: Recommended as the first-line treatment for advanced unresectable hepatocellular carcinoma (HCC), sorafenib has been shown to prolong median overall survival (OS) for patients. However, advanced HCC sees high heterogeneity across patient groups. Recently, a growing number of studies have...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Transl Med
Main Authors: Zhao, Shoujie, Zhang, Xiangnan, Wang, Mengmeng, Tan, Kai, Dou, Weijia, Fan, Qingling, Li, Huichen, Du, Xilin, Liu, Lei
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7290527/
https://ncbi.nlm.nih.gov/pubmed/32566613
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2020.02.83
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados